Evidence map›Paper›PMID 32745689›Full record

ReviewBone2020

MicroRNAs in cartilage development and dysplasia.

Maria Shvedova, Tatsuya Kobayashi

Open access · greenAbstract readReview
In one paragraph

Review in Bone, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. miRNA Target Prediction: An Overview of the Past and Current Tools.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Modulation of MicroRNA Expression During In Vitro Chondrogenesis.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maria ShvedovaEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Tatsuya KobayashiEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: kobayash@helix.mgh.harvard.edu.
Massachusetts General Hospital · US

Funding

Role of miR-17-92 miRNAs in skeletal development and bone homeostasisR01AR056645 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI KOBAYASHI, TATSUYA · 2010 to 2020
$4.1M
NIAMS NIH HHS R01 AR056645
6 · The paper itself

Abstract

Small regulatory microRNAs (miRNAs) post-transcriptionally suppress gene expression. MiRNAs expressed in skeletal progenitor cells and chondrocytes regulate diverse aspects of cellular function and thus skeletal development. In this review, we discuss the role of miRNAs in skeletal development, particularly focusing on those whose physiological roles were revealed in vivo. Deregulation of miRNAs is found in multiple acquired diseases such as cancer; however congenital diseases caused by mutations in miRNA genes are very rare. Among those are mutations in miR-140 and miR-17~92 miRNAs which cause skeletal dysplasias. We also discuss pathological mechanisms underlining these skeletal dysplasias.

Indexed as

MicroRNAsAnimalsBone DiseasesCartilageChondrocytesHumansStem CellsMicroRNAsCartilage developmentChondrocytesMicroRNAsmiR-140miR-17~92Skeletal dysplasia

Identifiers

PMID32745689
PMCPMC7502492
OpenAlexW3046452334

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.